13-cis-retinoic acid plus interferon α -2a: Highly active systemic theraphy for squamous cell carcinoma of the cervix

Journal of the National Cancer Institute

Volumn 84, Issue 4, 1992, Pages 241-245

  Lippman, Scott M ^a   Kavanagh, John J ^a   Paredes espinoza, Mario ^b   Delgadillo madrueño, Fernando ^b   Paredes casillas, Patricia ^b   Hong, Waun Ki ^a   Holderner, Eduardo ^c   Krakoff, Irwin H ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN; RECOMBINANT ALPHA2A INTERFERON;

ADULT; ADVANCED CANCER; AGED; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER STAGING; CHEILITIS; CLINICAL ARTICLE; CONJUNCTIVITIS; DRY SKIN; FATIGUE; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR REGRESSION; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CERVIX NEOPLASMS; DRUG EVALUATION; FEMALE; HUMAN; INTERFERON ALFA-2A; ISOTRETINOIN; MIDDLE AGE; REMISSION INDUCTION; SUPPORT, NON-U.S. GOV'T;

EID: 0026600705     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/84.4.241     Document Type: Article

References (53)

1. Boring CC, Squires TS, Tong T: Cancer statistics, 1991 [published erratum appears in CA Cancer J Clin 41:111, 1991]. CA Cancer J Clin 41:19-36, 1991
2. Devesa SS, Silverman DT, Young JL Jr, et al: Cancer incidence and mortality trends among whites in the United States, 1947-84. J Natl Cancer Inst 79:701-770, 1987
3. DiSaia PJ, Creasman WT: Clinical Gynecologic Oncology. St Louis: Mosby, 1989
4. World Health Organization: Control of cancer of the cervix uteri. Bull WHO 64:607-618, 1986
5. Whelan SL, Parkin DM, Masuyer E, eds: Patterns of Cancer in Five Continents. Lyon: IARC Sci Publ No. 102, 1990
6. Hoskins WJ, Perez C, Young RC: Gynecologic tumors. In Cancer: Principles and Practice of Oncology, 3rd ed. (DeVita VT Jr, Hellman S, Rosenberg SA, eds). Philadelphia: Lippincott, 1989, pp 1099-1161
7. Tobias J, Buxton EJ, Blackledge G, et al: Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer. Cancer Chemother Pharmacol 26 (suppl):S59-S62,1990
8. Souhami L, Gil R, Allan S, et al: A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix. J Clin Oncol 9:970-977, 1991
9. Hemmi H, Breitman TR: Combinations of recombinant human interferons and retinoic acid synergistically induced differentiation of the human promyelocytic leukemia cell line HL-60. Blood 69:501-507,1987
10. Peck R, Bollag W: Potentiation of retinoid-induced differentiation of HL-60 and U937 cell lines by cytokines. Eur J Cancer 27:53-57, 1991
11. Marth C, Daxenbichler G, Dapunt O: Synergistic antiproliferative effect of human recombinant interferons and retinoic acid in cultured breast cancer cells. J Natl Cancer Inst 77:1197-1202,1986
12. Marth C, Kirchebner P, Daxenbichler G: The role of polyamines in interferon and retinoic acid mediated synergistic antiproliferative action. Cancer Lett 44:55-59, 1989
13. Higuchi T, Hannigan GE, Malkin D, et al: Enhancement by retinoic acid and dibutyryl cyclic adenosine 3’:5’-monophosphate of the differentiation and gene expression of human neuroblastoma cells induced by interferon. Cancer Res 51:3958-3964,1991
14. Frey JR, Peck R, Bollag W: Antiproliferative activity of retinoids, interferon-α and their combination in five human transformed cell lines. Cancer Lett 57:223-227,1991
15. Agarwal C, Rorke EA, Irwin JC, et al: Immortalization by human papillomavirus type 16 alters retinoid regulation of human ectocervical epithelial cell differentiation. Cancer Res 51:3982-3989,1991
16. Tsang SS, Li G, Stich HF: Effect of retinoic acid on bovine papillomavirus (BPV) DNA-nduced transformation and number of BPV DNA copies. Int J Cancer 42:94-98, 1988
17. Reppucci AD, Dilorenzo TP, Abramson AL, et al: In vitro modulation of human laryngeal papilloma cell differentiation by retinoic acid. Otolaryngol Head Neck Surg 105:528-532, 1991
18. Lippman SM, Kessler JF, Meyskens FL Jr: Retinoids as preventive and therapeutic anticancer agents. Cancer Treat Rep 71:391-405 (part I), 493-515 (part II), 1987
19. Lippman SM, Meyskens FL Jr: Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. Ann Intern Med 107:499-502, 1987
20. Weiner SA, Surwit EA, Graham VE, et al: A phase I trial of topically applied transretinoic acid in cervical dysplasia—clinical efficacy. Invest New Drugs 4:241-244, 1986
21. Graham V, Surwit ES, Weiner S, et al: Phase II trial of β-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap. West J Med 145:192-195,1986
22. Androphy EJ: Papillomaviruses and interferon. Ciba Fund Symp 120:221-234,1986
23. Goldstein D, Laszlo J: The role of interferon in cancer therapy: A current perspective. CA 38:258-277,1988
24. Healy GB, Gelber RD, Trowbridge AL, et al: Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial. N Engl J Med 319:401-407, 1988
25. Choo YC, Seto WH, Hsu C, et al: Cervical intraepithelial neoplasia treated by perilesional injection of interferon. Br J Obstet Gynaecol 93:372-379,1986
26. Byrne MA, Möller BR, Taylor-Robinson D, et al: The effect of interferon on human papillomaviruses associated with cervical intraepithelial neoplasia. Br J Obstet Gynaecol 93:1136-1144,1986
27. Frost L, Skajaa K, Hvidman LE, et al: No effect of intralesional injection of interferon on moderate cervical intraepithelial neoplasia. Br J Obstet Gynaecol 97:626-630,1990
28. Yliskoski M, Cantell K, Syrjanen K, et al: Topical treatment with human leukocyte interferon of HPV 16 infections associated with cervical and vaginal intraepithelial neoplasias. Gynecol Oncol 36:353-357, 1990
29. Ikic D, Krŭsić J, Kirhmajer V, et al: Application of human leucocyte interferon in patients with carcinoma of the uterine cervix. Lancet 1:1027-1030, 1981
30. Krŭsić J, Kirhmajer V, Knežević M, et al: Influence of human leucocyte interferon on squamous cell carcinoma of the uterine cervix: Clinical, histological, and histochemical observations. III. Communication. J Cancer Res Clin Oncol 101:309-315,1981
31. Vasilyev RV, Bokhman JaV, Smorodintsev AA, et al: An experience with application of human leucocyte interferon for cervical cancer treatment. Eur J Gynecol Oncol 11:313-317, 1990
32. Lippman SM, Parkinson DR, Itri LM, et al: 13-cis-Retinoic acid and interferon α-2a: Effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 84:235-241,1992
33. Ajani JA, Welch SR, Raber MN, et al: Comprehensive criteria for assessing therapy-induced toxicity. Cancer Invest 8:147-159, 1990
34. Kasamatsu T, Ohmi K, Takeuchi S, et al: Clinical study of recombinant interferon alpha-2 (Sch 30500) in advanced gynecological cancers. Gan To Kagaku Ryoho 12:1656-1660, 1985
35. Hong WK, Endicott J, Itri LM, et al: 13-cis-Retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315:1501-1505, 1986
36. Hong WK, Lippman SM, Itri LM, et al: Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 323:795-801, 1990
37. Warrell RP Jr, Frankel SR, Miller WH Jr, et al: Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324:1385-1393,1991
38. Miller WH Jr, Warrell RP Jr, Frankel SR, et al: Novel retinoic acid receptor-α transcripts in acute promyelocytic leukemia responsive to all-trans-retinoic acid. J Natl Cancer Inst 82:1932-1933, 1990
39. Kraemer KH, Digiovanna JJ, Moshell AN, et al: Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 318:1633-1637, 1988
40. Quesada JR, Reuben J, Manning JT, et al: Alpha interferon for induction of remission in hairy-cell leukemia. N Engl J Med 310:15-18, 1984
41. Talpaz M, Kantarjian H, Kurzrock R, et al: Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients. Ann Intern Med 114:532-538, 1991
42. Evans RM: The steroid and thyroid hormone receptor superfamily. Science 240:889-895, 1988
43. Langer JA, Pestka S: Interferon receptors. Immunol Today 9:393-400,1988
44. Dutcher JP, Wadler S, Wiernik PH: Biologic response modifiers in gynecologic malignancies. Yale J Biol Med 61:367-378, 1988
45. Wadler S, Schwartz EL: Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: A review. Cancer Res 50:3473-3486,1990
46. Lotan R, Francis GE, Freeman CS, et al: Differentiation therapy. Cancer Res 50:3453- 3464,1990
47. Lippman SM, Lee JS, Lotan R, et al: Biomarkers as intermediate end points in chemoprevention trials. J Natl Cancer Inst 82:555-560,1990
48. Ingber D, Folkman J: Inhibition of angiogenesis through modulation of collagen metabolism. Lab Invest 59:44-51, 1988
49. Folkman J: Successful treatment of an angiogenic disease [editorial]. N Engl J Med 320:1211-1212,1989
50. Werness BA, Munger K, Howley PM: Role of the human papillomavirus oncoproteins in transformation and carcinogenic progression. In Important Advances in Oncology 1991 (De-Vita VT Jr, Hellman S, Rosenberg SA, eds). Philadelphia: Lippincott, 1991, pp 3-18
51. Kohler M, Janz I, Wintzer HO, et al: The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance. Anticancer Res 9:1537-1548,1989
52. Sporn MB, Roberts AB: TFG-β: Problems and prospects. Cell Regul 1:875-882,1990
53. Cope FO, Wille JJ: Retinoid receptor antisense DNAs inhibit alkaline phosphatase induction and clonogenicity in malignant keratinocytes. Proc Natl Acad Sci USA 86:5590-5594,1989